Financiación

2024

1. Development of new generation Tc-99m kits

2. Actividades CRO TranspoCART

3. Pruebas PET Amiloide y PET Tau

   euro 24.600,00

4. FOXO as a central axis in DMG response to therapy.

   euro 61.020,00

5. Desarrollo de células CAR-T de cuarta generación (TRUCKs) mu

6. Estudio experimental del ácido hidroxicítrico (FagolitosPlus

7. Rational to modulate the Microbiome-induced Endoplasmic Reticulum stress as tool to avoid the immune evasion in Hepatocellular Carcinoma (RETO)

   euro 42.162,00

8. ACUERDO SHARE

9. Role of amino acid metabolism reprogramming and calpain deregulation in fibroblasts activation and diffuse myocardial fibrosis in heart failure

   euro 150.000,00

10. Propósito personal

    euro 35.000,00

11. Bridge MDACC-FIMA-CUN

12. Diverging HFpEF Phenotypes : patient-tailoreD targeting of anti-Inflammatory pathways to limit Ventricular and Atrial remodelling

    euro 198.750,00

13. PIPO_Phase I prognostic online tool

    euro 10.780,00

14. Subcontratación Desarrollo de neuromoduladores

    euro 303.375,00

15. Immunomodulation of the tumor microenvironment in DIPG by oncolytic virotherapy.

    euro 126.000,00

16. Improvement of facial laceration suturing task trainer

17. Estudio SHARE

18. Overcoming resistance to oncolytic viruses for the treatment of Pediatric Diffuse Midline Gliomas

    euro 300.000,00

19. Identificación de microproteínas (MPs) para generar vacunas contra el cáncer. ALBA (Antigens for Liver and Breast Anticancer vaccines).

    euro 72.010,00

20. "Microplásticos y microbiota en la salud cardiometabólica: soluciones BIOlógicas innovadoras para la DEtección y prevención de TOXicos (BioDETOX)¿.

    euro 79.856,00